Citigroup’s Guardian Pharmacy Services GRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$650K Buy
15,515
+12,180
+365% +$472K ﹤0.01% 3759
2026
Q1
$126K Sell
3,335
-8,342
-71% -$273K ﹤0.01% 4198
2025
Q4
$351K Buy
11,677
+9,257
+383% +$262K ﹤0.01% 3741
2025
Q3
$63.5K Sell
2,420
-3,034
-56% -$72.3K ﹤0.01% 4418
2025
Q2
$116K Sell
5,454
-572
-9% -$12.9K ﹤0.01% 4336
2025
Q1
$128K Sell
6,026
-711
-11% -$14.6K ﹤0.01% 4456
2024
Q4
$136K Buy
+6,737
New +$139K ﹤0.01% 4673

Other funds holding GRDN

Citigroup's GRDN Position: Q2 2026 in Review

Citigroup increased its Guardian Pharmacy Services (GRDN) stake by 365% in Q2 2026, buying an estimated $472K and bringing the position to 15,515 shares worth $650K. The position accounts for ﹤0.01% of the portfolio, ranked #3759.

Citigroup first reported a position in GRDN in Q4 2024 and has held it in 7 quarters since. 190 funds tracked by Wall St. Rank hold GRDN as of Q2 2026.

  • Citigroup held 15,515 shares of Guardian Pharmacy Services worth $650K as of Q2 2026.
  • Citigroup bought 12,180 Guardian Pharmacy Services shares in Q2 2026, an estimated $472K.
  • Guardian Pharmacy Services made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #3759 holding.
  • Citigroup first reported a position in Guardian Pharmacy Services in Q4 2024 and has held it in 7 quarters since.
  • 190 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.